Music Therapy for Children With Autism Spectrum Disorder.
Sarabeth Broder-Fingert, Emily Feinberg, Michael Silverstein
https://pubmed.ncbi.nlm.nih.gov/28787492/Actively Recruiting
Led by Prof Simon Baron-Cohen · Updated on 2025-03-25
240
Participants Needed
2
Research Sites
N/A
Total Duration
Researchers are evaluating the effectiveness of individual improvisational music therapy sessions for autistic children aged 7 to 11. This trial compares adding these music therapy sessions to usual care against usual care alone over 12 weeks. The study aims to understand how music therapy impacts social communication, communication skills, psychosocial problems, wellbeing, adaptive functioning, anxiety, and the therapeutic relationship in autistic children. Participants will be randomly assigned to either the intervention group, receiving twice-weekly 30-minute individual improvisational music therapy sessions for 12 weeks, or the control group, receiving routine support from general practitioners, mental health, and educational professionals without additional music therapy. The therapy is delivered by qualified music therapists using a structured training manual. The study includes baseline assessments before randomization, a primary endpoint at 13 weeks, and a secondary endpoint at 39 weeks post-randomization. During the trial, participants will undergo evaluations including video-recorded sessions and various standardized questionnaires to measure social communication changes, communication skills, psychosocial difficulties, wellbeing, adaptive functioning, and anxiety. Data collection occurs at baseline, 13 weeks end of intervention, and 39 weeks 6 months post-intervention. Researchers will also assess the link between the therapeutic relationship and progress in social and communication skills. The study concludes after the final follow-up data collection.
CONDITIONS
Autism - Children's Improvisational Music Therapy Evaluation
S
Simon Baron-Cohen, Professor
A
Artur Jaschke, PhD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Prof Simon Baron-Cohen
Lead Sponsor
Anglia Ruskin University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants randomized to the intervention group receive 30-minute individual improvisational music therapy sessions twice a week for 12 weeks. Those in the control group continue with support as usual without music therapy.
Up to 24 music therapy sessions for the intervention group; assessments at baseline and 13 weeks post-randomisation
Duration - Approximately 26 weeks after treatment
Participants continue with assessments to evaluate outcomes 39 weeks after randomisation (6 months after the end of the music therapy intervention).
1 follow-up assessment visit
Study Type
INTERVENTIONAL
Masking
SINGLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Sarabeth Broder-Fingert, Emily Feinberg, Michael Silverstein
https://pubmed.ncbi.nlm.nih.gov/28787492/A Blythe LaGasse
https://pubmed.ncbi.nlm.nih.gov/25053766/Sam Porter, Tracey McConnell, Katrina McLaughlin...
https://pubmed.ncbi.nlm.nih.gov/27786359/C Gold, T Wigram, C Elefant
https://pubmed.ncbi.nlm.nih.gov/16625601/S Hollis, F Campbell
https://pubmed.ncbi.nlm.nih.gov/10480822/Thomas Rabeyron, Juan-Pablo Robledo Del Canto, Emmanuelle Carasco...
https://pubmed.ncbi.nlm.nih.gov/32798927/Patrick E Savage, Psyche Loui, Bronwyn Tarr...
https://pubmed.ncbi.nlm.nih.gov/32814608/Darcy D Walworth, Dena Register, Judy Nguyen Engel
https://pubmed.ncbi.nlm.nih.gov/19757876/T Moritz Schladt, Gregory C Nordmann, Roman Emilius...
https://pubmed.ncbi.nlm.nih.gov/28959197/Jonathan Green, Tony Charman, Helen McConachie...
https://pubmed.ncbi.nlm.nih.gov/20494434/Prof Simon Baron-Cohen
Lead Sponsor
Anglia Ruskin University
Collaborating Sponsor